← FDA Drug Approvals (Drugs@FDA)
EMGALITY
BLA · Biologics License Application · Sponsor: ELI LILLY AND CO · Approved 2018-09-27
Drug application
- FDA Application #
BLA761063- Application type
- Biologics License Application
- Brand name
- EMGALITY
- Generic name
- GALCANEZUMAB-GNLM
- Active ingredients
- GALCANEZUMAB-GNLM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- ELI LILLY AND CO
- Manufacturer
- Eli Lilly and Company
- First approval
- 2018-09-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown